Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.

Journal of virological methods - 1 Jul 2012

Cañadas María-Paz, Cirigliano Vincenzo, Darwich Laila, Sirera Guillermo, Coll Josep, Clotet Bonaventura, Videla Sebastian

Abstract excerpt

Human papillomavirus genotyping is being considered in cervical screening programs and for monitoring the effectiveness of HPV vaccination. Both approaches require access to fast, easy and high-throughput technology. The aim of this study was to compare a new commercial assay (f-HPV typing™) with the Hybrid Capture II® (HC2) to detect HPV infection. The F-HPV typing is a multiplex fluorescent PCR method...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cervix Uteri
Share to Clinical Laboratory Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Diagnostic Techniques

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Reagent Kits, Diagnostic

Share to Sensitivity and Specificity

Share to Virology

Source

Identifiers

PMID: 22449759
DOI: 10.1016/j.jviromet.2012.03.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.PMID 22449759Read ↗

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.Semantic proximity Read ↗

Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.Semantic proximity Read ↗

Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.Semantic proximity Read ↗

Concordance in cervical HPV detection between hybrid capture 2 and HPV GenoArray tests.Semantic proximity Read ↗

Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II.Semantic proximity Read ↗

Repurposing the Hybrid Capture 2 (HC2) screening test for whole-genome sequencing of human papillomaviruses.Semantic proximity Read ↗

CHAPTER 7 Methods for detection of HPV infection and its clinical utilitySemantic proximity Read ↗

High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests.Semantic proximity Read ↗

Chapter 12: Human Papillomavirus TechnologiesSemantic proximity Read ↗

Evaluation of a Novel Single-Tube Method for Extended Genotyping of Human Papillomavirus.Semantic proximity Read ↗

Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance.Semantic proximity Read ↗

Comparison of HPV genotyping assays and Hybrid Capture 2 for detection of high-risk HPV in cervical specimens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.